Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Spain
  • Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Study of Bintrafusp Alfa and Doxorubicin Hydrochloride for Adults with Advanced Soft-Tissue Sarcoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study of Sasanlimab and Sacituzumab Govitecan for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Spain
  • Study of Pembrolizumab and Azacitidine for Patients with Acute Myeloid Leukemia Facing Imminent Relapse

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of Acalabrutinib Alone or with Rituximab for Patients with Relapsed/Refractory Marginal Zone Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation

    Not recruiting

    1 1 1
    Investigated Drugs:
    Italy
  • Study on the Effectiveness of Sodium Chloride and Sodium Citrate in Intensive Care Patients Undergoing Continuous Kidney Purification

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of Durvalumab and Regorafenib for Patients with Stage IV Colorectal Cancer with No Evidence of Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of Durvalumab, Carboplatin and Etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy